1. Heteryunine A, an amidated tryptophan-catechin-spiroketal hybrid with antifibrotic activity from Heterosmilax yunnanensis.
- Author
-
Du RR, Wang RY, Zhou JC, Gao HH, Qin WJ, Duan XM, Yang YN, Zhang XW, and Zhang PC
- Subjects
- Molecular Structure, Structure-Activity Relationship, Antifibrotic Agents pharmacology, Antifibrotic Agents chemistry, Antifibrotic Agents isolation & purification, Hepatic Stellate Cells drug effects, Hepatic Stellate Cells metabolism, Dose-Response Relationship, Drug, Cell Movement drug effects, Animals, Spiro Compounds chemistry, Spiro Compounds pharmacology, Humans, Plant Roots chemistry, Catechin chemistry, Catechin pharmacology, Catechin isolation & purification, Tryptophan chemistry, Tryptophan pharmacology, Cell Proliferation drug effects
- Abstract
An unprecedented spiro-C-glycoside adduct, heteryunine A (1), along with two uncommon alkaloids featuring a 2,3-diketopiperazine skeleton, heterpyrazines A (2) and B (3), were discovered in the roots of Heterosmilax yunnanensis. The detailed spectroscopic analysis helped to clarify the planar structures of these compounds. Compound 1, containing 7 chiral centers, features a catechin fused with a spiroketal and connects with a tryptophan derivative by a CC bond. Its complex absolute configuration was elucidated by rotating frame overhauser enhancement spectroscopy (ROESY), specific rotation, and the
13 C nuclear magnetic resonance (NMR) and electronic circular dichroism (ECD) calculation. The possible biosynthetic routes for 1 were deduced. Compounds 1 and 2 showed significant antifibrotic effects and further research revealed that they inhibited the activation, migration and proliferation of hepatic stellate cells (HSCs) through suppressing the activity of Ras homolog family member A (RhoA)., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF